G04CA03 terazosin
ATC group of level 5 – chemical substance · in plain English: medicines for an enlarged prostate
This site has the patient leaflet or the SPC of 3 medicines in this group.
- 3 prescription only (POM)
Active substance: Terazosin – all medicines with this substance, also in combinations.
Place in the ATC classification
- G Genito urinary system and sex hormones 815 medicines
- G04 Urologicals 373 medicines
- G04C Drugs used in benign prostatic hypertrophy 62 medicines
- G04CA Alpha-adrenoreceptor antagonists, benign prostatic hypertrophy 52 medicines
- G04CA03 terazosin 3 medicines
- G04CA Alpha-adrenoreceptor antagonists, benign prostatic hypertrophy 52 medicines
- G04C Drugs used in benign prostatic hypertrophy 62 medicines
- G04 Urologicals 373 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Terazosin 10 mg tablets SPC | Prescription only (POM) |
| Terazosin 2 mg tablets SPC | Prescription only (POM) |
| Terazosin 5 mg tablets SPC | Prescription only (POM) |
Other groups of the same level
- G04CA01 alfuzosin 12 medicines
- G04CA02 tamsulosin 24 medicines
- G04CA04 silodosin 3 medicines
- G04CA52 tamsulosin and dutasteride 5 medicines
- G04CA53 tamsulosin and solifenacin 5 medicines
Other names of the ATC group
- Czech: G04CA03 Terazosin
- French: G04CA03 térazosine
- German: G04CA03 Terazosin
- Spanish: G04CA03 TERAZOSINA
- German: G04CA03 Terazosin
- Polish: G04CA03 TERAZOSIN
- Turkish: G04CA03 terazosin
- Portuguese (Brazil): G04CA03 Terazosina
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group G04CA03
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.